vapreotide: Clinical Trials

2 trials of vapreotide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow vapreotide: new trials by email Literature Review of vapreotide trials Research Report on vapreotide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
Sanvar® (vapreotide) - Esophageal Varices, Portal Hypertension
Phase 3CompletedDebiovision702006-05-012008-07-08
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
vapreotide, conventional surgery - Pancreatic Cancer, Perioperative/Postoperative Complications
Phase 3TerminatedMayo Clinic2001-03-012010-08-10

Conditions studied

Esophageal and Gastric Varices (1)  ·  Fibrosis (1)  ·  Hypertension, Portal (1)  ·  Liver Cirrhosis (1)  ·  Pancreatic Neoplasms (1)  ·  Postoperative Complications (1)

Sponsors

Debiovision (1)  ·  Mayo Clinic (1)

Countries

United States (2)

Top investigators

Adrian Reuben, M.D. (1)  ·  Alvaro Koch, M.D. (1)  ·  Arun J. Sanyal, M.D. (1)  ·  Daniel R. Ganger, M.D. (1)  ·  Gary A. Abrams, M.D. (1)  ·  Hugo Vargas, M.D. (1)  ·  James F. Trotter, M.D. (1)  ·  Jeffrey S. Crippin, M.D. (1)  ·  Joseph Lim, M.D. (1)  ·  Kimberly Beavers, M.D., M. Ph. (1)  ·  Michael B. Fallon, M.D. (1)  ·  Michael G. Sarr, MD, FACS (1)  ·  Michele D. Bishop, M.D. (1)  ·  Naga P. Chalasani, M.D. (1)  ·  Nezam H. Afdhal, M.D. (1)

NIH funding

P30CA015083 (1)